Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series
Vickyanne Carruthers(Great North Children's Hospital), Gareth J. Veal(Newcastle University), Rebecca Rees(Newcastle University), Catherine Graham(University of Cambridge), Olga Slater(Great Ormond Street Hospital), Sarah Brown(University of Leeds), Tasnim Arif(Great North Children's Hospital), S. Barnett(Newcastle University), Ramya Ramanujachar(University College London), Katie N. Johnson(Leonardo (United States)), G.A. Amos Burke(Inserm)
Cited by 4
Related Papers
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
|The Lancet|2015|477
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
|The Lancet Oncology|2013|392
Clinical development of new drug–radiotherapy combinations
|Nature Reviews Clinical Oncology|2016|317
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
|New England Journal of Medicine|2020|308